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Introduction
In a previous Hints and Kinks, we discussed the role of
causal inference in tasks of health services research (HSR)
using examples from health system interventions (Moser
et al. 2020). In the present Hints and Kinks, we more for-
mally introduce a principled framework for causal infer-
ence. Specifically, we discuss in more detail the role of
counterfactuals for the definition of a causal effect and the
‘association is not causation’ adage. We continue on the
example of a hospital merger (HM) as a health system
intervention.
Counterfactuals and causal effect
We introduced counterfactuals as hypothetical outcomes
which are actually not observed in a real-world setting
(Herna´n 2004). We used an example of a HM, where we
were interested in the causal question whether a HM
reduces hospital readmissions (Moser et al. 2020). To
answer this question, we need to define a causal effect, a
statistical measure which relates probabilities of hospital
readmissions when (1) every patient is treated under the
situation of a HM versus (2) the HM would not have been
implemented. Note that we never observe one of the two
situations, because either the HM is implemented or not,
but not both. We now introduce a formal notation for
causal inference which allows us to mathematically define
a causal effect.
For each patient, we would like to know his or her
outcome (here, a hospital readmission) if the HM had not
been implemented (denoted as YnoHM) together with the
outcome under the HM (denoted as YHM). The superscripts
denote the counterfactual outcomes we can formalize, but
which are actually not observed: Only YHM can be observed
if the HM is implemented. An average causal effect in the
study population can then be defined by the risk difference
Probability(YHM = 1)–Probability(YnoHM = 1), abbrevi-
ated as RDCausal. Note that we could also use other risk
measures, for example a relative risk, for the definition of a
causal effect. The choice of the used effect measure
depends on the research question because the underlying
scale (i.e., an additive scale for a risk difference or multi-
plicative scale for a risk ratio) influences its final inter-
pretation (Herna´n and Robins 2020).
An important question remains: How can we assess an
effect measure based on outcomes which are actually not
observed? One could compare the outcomes in the region
with HM to outcomes in a ’control’ region with no HM.
Table 1 shows hypothetical patients with (known) coun-
terfactual outcomes and actually observed outcomes (de-
noted with subscripts YnoHM, YHM, YObserved). For example,
the patient with ID 5 was treated in the HM region with no
observed hospital readmission (YObserved = 0). The
observed outcome is equal to the counterfactual outcome in
the HM region (YObserved = YHM = Y
HM = 0). Note that if
this patient would have been treated in the control region,
he or she would have had a readmission (YnoHM = 1).
Because this patient is actually only observed in the HM
region, one will never observe the outcome of the control
region (YnoHM is missing). The mathematical notation for
counterfactuals might be initially confusing, yet it is a
necessary component for a causal inference framework.
What is the average causal effect in the study population
from Table 1? We get that the risk difference RDCausal is
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zero, because Probability(YHM = 1) = 3/5 and Probabil-
ity(YnoHM = 1) = 3/5. Thus, the HM does not reduce
hospital readmissions.
Association versus causation
An associational effect measure generally compares risks
in subsets of a study population by conditioning on certain
study characteristics (see Fig. 1) (Herna´n 2004). In the
example of Table 1, one relates the risk of hospital read-
missions among patients in the HM region with the risk
among patients in the control region. Let us define
RDAssociational
:¼ Probability YObserved ¼ 1 among patients in the HM region 
 Probability YObserved ¼ 1 among patients in the control region ;
as the associational risk difference in the study population.
We obtain from Table 1 that the first expression of
RDAssociational is 0 (two patients were treated in the HM
region without an observed hospital readmission) and the
second expression 1/3 (three patients were treated in the
control region with one hospital readmission). Thus,
RDAssociational is equal to 0–1/3 = –1/3, i.e., the risk of
hospital readmissions in the HM region is lower compared
to the risk in the control region.
The difference between the derived causal effect
RDCausal and the associational effect RDAssociational leads to
the famous ‘association is not causation’ adage. Likely
because of this adage, many researchers in HSR avoid any
causal terminology, especially when they use ‘only’
observational data (Herna´n 2018). They argue that the
above comparison of outcomes between an ‘intervention’
and a ‘control’ region does not allow for any causal con-
clusions because the regions differ in several ways, for
example, due to the case mix of treated patients, the skill-
grade mix of medical personnel or the availability of health
care services. When a study design randomly allocates
patients before hospital entry to either the HM region or the
control region (and patients and health care providers
perfectly comply with that assignment), researchers would
interpret statistical findings as causal. But in fact, many
studies in HSR are observational studies without a random
allocation of patients to treatment groups. Still, often only
‘descriptive’ and ‘modeling’ approaches are then used to
support decision-making in health systems, even if the
background is inherently causal. Whether the reported
effect measure should be used from a causal inference
approach or from descriptive and modeling approaches
strongly depends on the intended HSR question.
How can researchers integrate ‘causality’ in HSR? Our
above introduced components of a framework for causal
inference is the backbone for modern causal inference.
Modern causal inference allows for inference which
mimics a situation as if patients would have been assigned
by random allocation, despite using an observational study
design. Topics for recent calls of causal inference
approaches in HSR include, for example, comparative
effectiveness research, payment scheme evaluations, health
care utilization or the use of simulation studies (see
Table 2). Principles of modern causal inference are
described and explained in several textbooks (van der Laan
and Sherri 2011; Pearl et al. 2016; Herna´n and Robins
2020).
Table 1 Study population of five patients
ID Region YnoHM YHM YnoHM YHM YObserved
1 No HM 0 1 0 NA 0
2 No HM 0 1 0 NA 0
3 No HM 1 1 1 NA 1
4 HM 1 0 NA 0 0
5 HM 1 0 NA 0 0
HM Hospital merger, NA Not available, YnoHM Counterfactual out-
come in the region with no HM, YHM Counterfactual outcome in the
HM region, YnoHM Counterfactual outcome in the region with no HM,
actually observed in the real world, YHM Counterfactual outcome in
the HM region, actually observed in the real world, YObserved
Observed outcome
In bold: the patient described in the manuscript
Patient study population
vs.vs.
AssociationCausation
Region with no hospital merger Hospital merger region
Fig. 1 Graphical explanation of ‘association versus causation’ using
the example of a hospital merger as a health system intervention.
Study outcome: Hospital readmissions. ‘Association’ compares
relationships in subsets of a study population, indicated by the
separated triangles. For example, one compares the risk of hospital
readmissions among patients treated in a region with a hospital
merger and among patients treated in a region without a hospital
merger. ‘Causation’ compares situations (i.e. ‘what-if’ questions)
between hypothetical study populations. For example, one compares
hospital readmissions in a population where every patient would have
been treated in a region with a hospital merger with a population
where every patient would have been treated in the same region, but
without a hospital merger Source: Figure adapted from Herna´n (2004)
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Discussion
In the present Hints and Kinks, we introduced components
for a principled framework for causal inference in HSR.
Because ‘causal inference’ is conceptually different from
‘description’ or ‘modeling’, HSR needs the integration of a
causal inference framework which includes a specific
notation, definitions and analysis techniques to extend the
traditional tasks of ‘description’ and ‘modeling’. Public
health decision-making which solely relies on associational
effect measures might lead to inappropriate decisions
because questions about optimal decision-making are
inherently causal. We plea that students and researchers in
the field of HSR are aware of the different available
frameworks to successfully address ‘description’, ‘model-
ing’ and ‘causal inference’, depending on the intended
research question.
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